Discover why Fulgent’s accelerating revenue and rising margins signal growth potential, with shares undervalued vs. cash.
According to Kadam, scientific and technological advancements in genomics over the past decade have driven affordability and ...
High-grade serous carcinoma is a rare diagnosis in cervical biopsies. Cervical serous carcinoma is no longer recognized as a primary cervical tumor in ...
ARK Invest, formally known as ARK Investment Management LLC, is a U.S.-based investment firm founded by Cathie Wood, famous ...
Researchers have uncovered an unusual survival strategy in Iberian harvester ants that turns basic biology on its head: The ...
AZoLifeSciences on MSN
RNAConnect® Announces Commercial Launch of UltraMarathonRT® cDNA Synthesis and Amplification Kit for Enhanced Short-Read RNA Sequencing
RNAConnect, a leader in next-generation molecular biology tools, today announced the commercial launch of the UltraMarathonRT cDNA Synthesis and Amplification Kit, designed to elevate short-read RNA ...
Nautilus Biotechnology, Inc. ( NASDAQ: NAUT) Morgan Stanley 23rd Annual Global Healthcare Conference September 8, 2025 1:50 PM EDT Hello. Hi. My name is Yuko Oku, and I work on the Life Science Tools ...
Zacks Investment Research on MSN
3 Promising Genomics & Synthetic Biology Stocks in Spotlight in 2025
An updated edition of the July 30, 2025, article. Genomics involves a thorough study of genomes (an organism’s complete set of deoxyribonucleic acid or DNA). It involves understanding how genes ...
BST] Alternative time zones Unlock the potential for faster, more comprehensive leukemia characterization with this webinar from Dana-Farber Cancer Institute expert Salvatore Benfatto. Acute leukemia ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback